SANDRA CYRIL
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant MIAMI, FL NPI 1184653271
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant FL LEO Pharma Inc. All categories
General Payments — all program years on this page
$9,444.55
- Category: General Payments
- Program years: PY2021–2024
- Record count: 219
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,976.65 across 58 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,057.65 | 56 |
| Consulting Fee | $820.00 | 1 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| LEO Pharma Inc. | $1,104.87 | 6 |
| Dermavant Sciences, Inc. | $451.89 | 18 |
| Galderma Laboratories, L.P. | $258.46 | 2 |
| PFIZER INC. | $148.27 | 3 |
| Janssen Biotech, Inc. | $144.96 | 3 |
| E.R. Squibb & Sons, L.L.C. | $121.96 | 2 |
| Incyte Corporation | $107.88 | 2 |
| ABBVIE INC. | $107.04 | 5 |
| UCB, Inc. | $101.10 | 2 |
| GENZYME CORPORATION | $91.81 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $68.20 | 2 |
| Arcutis Biotherapeutics, Inc. | $57.06 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $56.65 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $41.29 | 2 |
| Regeneron Healthcare Solutions, Inc. | $26.29 | 1 |
| Amgen Inc. | $20.93 | 1 |
| Biofrontera Inc. | $18.99 | 1 |
| Verrica Pharmaceuticals Inc. | $18.08 | 1 |
| Helsinn Therapeutics (U.S.), Inc. | $17.34 | 1 |
| Krystal Biotech Inc | $13.58 | 1 |
By program year
Records — PY2024 (58)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.